Related references
Note: Only part of the references are listed.Numeric analysis of reversibility of classic movement equations and constructive criteria of estimating quality of molecular dynamic simulations
Ivan Yu. Torshin et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening
Samir Chtita et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2021)
Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease
Alexander M. Andrianov et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging
Wioletta Rut et al.
NATURE CHEMICAL BIOLOGY (2021)
Antiretrovirals for Prophylaxis Against COVID-19: A Comprehensive Literature Review
Golbarg Alavian et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Functional and molecular evaluation of using aliskiren during acute and chronic partial ureteral obstruction in rat solitary kidney
Mohamed Essam et al.
LIFE SCIENCES (2021)
Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system
Man Lung Yeung et al.
CELL (2021)
Effect of nelfinavir stereoisomers on coronavirus main protease: Molecular docking, molecular dynamics simulation and MM/GBSA study
Mohsen Sargolzaei
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2021)
Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea
Jungchan Park et al.
PLOS ONE (2021)
Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study
Rana H. Refaey et al.
VIROLOGY (2021)
Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
Simon B. Gressens et al.
FRONTIERS IN PHYSIOLOGY (2021)
Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry
Giuseppe De Luca et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019
Eliecer Coto et al.
EUROPEAN CARDIOLOGY REVIEW (2021)
Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies
Safa Daoud et al.
ACTA PHARMACEUTICA (2021)
The use of aliskiren as an antifibrotic drug in experimental models: A systematic review
Thaina Altarejo Marin et al.
DRUG DEVELOPMENT RESEARCH (2020)
Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules
Krishnappa Ramya et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy
Anas Shamsi et al.
BIOSCIENCE REPORTS (2020)
Clinical efficacy, safety and tolerability of Aliskiren Monotherapy (AM): an umbrella review of systematic reviews
Qiyuan Zhao et al.
BMC CARDIOVASCULAR DISORDERS (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Aliskiren ? A promising antioxidant agent beyond hypertension reduction
Saeed Alshahrani
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
The renin-angiotensin system - a therapeutic target in COVID-19?
Beattie R. H. Sturrock et al.
CLINICAL MEDICINE (2020)
Lack of antiviral activity of darunavir against SARS-CoV-2
Sandra De Meyer et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study
Junmei Wang
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Interaction between RAAS inhibitors and ACE2 in the context of COVID-19
Jean-Jacques Mourad et al.
NATURE REVIEWS CARDIOLOGY (2020)
Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study
Faezeh Sadat Hosseini et al.
LIFE SCIENCES (2020)
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
Lifeng Fu et al.
NATURE COMMUNICATIONS (2020)
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
Alice Douangamath et al.
NATURE COMMUNICATIONS (2020)
Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach
Purushothaman Indu et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)
Evaluation of the Binding Affinity of Anti-Viral Drugs against Main Protease of SARS-CoV-2 Through a Molecular Docking Study
Milon Mondal et al.
Infectious Disorders - Drug Targets (2020)
Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA
Martiniano Bello et al.
JOURNAL OF MOLECULAR MODELING (2020)
A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules
Devendra Kumar et al.
BIOORGANIC CHEMISTRY (2020)
Computational Evaluation of the Inhibition Efficacies of HIV Antivirals on SARS-CoV-2 (COVID-19) Protease and Identification of 3D Pharmacophore and Hit Compounds
Vinod P. Raphael et al.
ADVANCES IN PHARMACOLOGICAL AND PHARMACEUTICAL SCIENCES (2020)
Aliskiren decreases oxidative stress and angiogenic markers in retinal pigment epithelium cells
Sonia Simao et al.
ANGIOGENESIS (2017)
Aliskiren targets multiple systems to alleviate cancer cachexia
Chaoyi Wang et al.
ONCOLOGY REPORTS (2016)
Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview
Fabio Angeli et al.
EXPERT OPINION ON DRUG SAFETY (2012)
Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases
Azhar Rashikh et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2012)
The SPASIBA force field for chondroitin sulfate: Vibrational analysis of D-glucuronic and N-acetyl-D-galactosamine 4-sulfate sodium salts
M. Meziane-Tani et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2006)
Molecular modeling of organic and biomolecular systems using BOSS and MCPRO
WL Jorgensen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Free energies of hydration from a generalized Born model and an ALL-atom force field
WL Jorgensen et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2004)
Increasing normal modes analysis accuracy: The SPASIBA spectroscopic force field introduced into the CHARMM program
P Lagant et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2004)
The SPASIBA force field as an essential tool for studying the structure and dynamics of saccharides
G Vergoten et al.
BIOCHIMIE (2003)